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Experimental Methods
• MRI is a non-invasive imaging
modality that uses a magnetic
field and radiofrequencies to
manipulate protons within the
body.
• Complete synthesis of the library of Europium (III) 
complexes.
• Investigation of PARACEST MRI properties and 
Luminescence of each complex.
Introduction and Background
Optical Imaging
• Optical Imaging 
is a highly 
sensitive imaging 
modality that 
uses visible light 
to visualize soft 
tissue.
• Lanthanide ions exhibit optical imaging properties however 
the amount of energy needed to directly excite these ions 
could be potentially damaging to biological tissue.
• To overcome this limitation, organic chromophores can be
used as an “antenna” to absorb the incident light and transfer
the energy obtained to the attached lanthanide ion,
sensitizing its luminescence.
The Antenna Effect
• The goal of this project is to synthesize a library of Europium
(III) complexes containing quinolines and assess how the
position of the amide substituent affects luminescence.
• Our hypothesis is that the variation in amide position will alter 
the electronic properties of the quinoline antenna, and this will 
be reflected in the luminescence  intensities of the 
complexes. 
Structures of Proposed Library of Europium (III) Complexes
Synthetic Scheme of Europium (III) Complexes
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Results
¹H-NMR Spectrum of BA-4 in CDCl₃ at 500 MHz ¹³C-NMR Spectrum of BA-4 in CDCl₃ at 125 MHz
¹H-NMR Spectrum of BA-6 in D₂O at 500 MHz ¹³C-NMR Spectrum of BA-6 in D₂O at 125 MHz
Results (contd.)
Reaction Conditions and Analysis
¹H-NMR Spectrum of Eu-BA-6 in D₂O at 500 MHz
Future Plans
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equivalents, respectively.
• Trialkylation of BA-1 was conducted using Bromo
acetyl-glycine-tert-butyl ester in 3.1:1 molar
equivalents of ester to BA-1.
• BA-4 was purified by flash chromatography using
DCM and ethanol as solvents.
• The tert-butyl esters were removed by TFA to produce
BA-6 and the final complex was synthesized with
addition of the Europium ion.
• Identities of all compounds were confirmed by ¹H-
NMR and ¹³C-NMR spectroscopy.
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• Eu-BA-6 emits red 
luminescence upon excitation by 
a UV lamp at 302 nm.
• This luminescence is evidence 
of sensitization of the Europium 
(III) ion by the quinoline 
substituent.
Luminescence of Eu-BA-6 in D₂O
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Magnetic Resonance Imaging (MRI)
• The chemical shift window is expanded due to the
lanthanide induced shifts of the paramagnetic Europium
ion.
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Figure 1. Bodily protons are 
manipulated in MR scans. [1]
Figure 2. Contrast agents allow for 
higher resolution MR images. [2]
Figure 3. Using a charged coupled device, 
images of biological tissue are generated with 
luminescent probes. [3]
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Figure 4. Visual diagram of antenna effect [4].
